Skip to menu Skip to content Skip to footer

2012

Journal Article

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease

Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012). High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 (1), 66-70.

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease

2011

Journal Article

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes

Nguyen-Van, Do, Keane, Colm, Han, Erica, Jones, Kimberley, Nourse, Jamie P., Vari, Frank, Ross, Nathan, Crooks, Pauline, Ramuz, Olivier, Green, Michael, Griffith, Lyn, Trappe, Ralf, Grigg, Andrew, Mollee, Peter and Gandhi, Maher K. (2011). Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes. American Journal of Blood Research, 1 (2), 146-159.

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes

2011

Journal Article

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Coiffier, Bertrand, Osmanov, Evgenii A., Hong, Xiaonan, Scheliga, Adriana, Mayer, Jiri, Offner, Fritz, Rule, Simon, Teixeira, Adriana, Walewski, Jan, de Vos, Sven, Crump, Michael, Shpilberg, Ofer, Esseltine, Dixie-Lee, Zhu, Eugene, Enny, Christopher, Theocharous, Panteli, van de Velde, Helgi, Elsayed, Yusri A., Zinzani, Pier Luigi, LYM-3001 study investigators and Mollee, Peter (2011). Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. The Lancet Oncology, 12 (8), 773-84. doi: 10.1016/S1470-2045(11)70150-4

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

2011

Journal Article

Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study

Mollee, P., Jones, M., Stackelroth, J., van Kuilenburg, R., Joubert, W., Faoagali, J., Looke, D., Harper, J. and Clements, A. (2011). Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. Journal of Hospital Infection, 78 (1), 26-30. doi: 10.1016/j.jhin.2011.01.018

Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study

2011

Journal Article

Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia

Weston, H., Cowell, V., Grimmett, K., Saal, R., Jones, M., Mills, T., Gill, D., Marlton, P., Bird, R. and Mollee, P. (2011). Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia. Internal Medicine Journal, 41 (5), 408-415. doi: 10.1111/j.1445-5994.2010.02334.x

Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia

2011

Journal Article

Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: Results from an Australian population

Morris, Kirk, Weston, Helen, Mollee, Peter, Marlton, Paula, Gill, Devinder and Kennedy, Glen (2011). Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: Results from an Australian population. Leukemia and Lymphoma, 52 (1), 85-91. doi: 10.3109/10428194.2010.532889

Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: Results from an Australian population

2011

Journal Article

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

Keane, Colm, Mollee, Peter, Marlton, Paula and Gill, Devinder (2011). Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population. Annals of Hematology, 90 (3), 359-360. doi: 10.1007/s00277-010-1023-0

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

2011

Journal Article

Proteomics in molecular diagnosis: typing of amyloidosis

Loo, Dorothy, Mollee, Peter N., Renaut, Patricia and Hill, Michelle M. (2011). Proteomics in molecular diagnosis: typing of amyloidosis. Journal of Biomedicine and Biotechnology, 2011 (1) 754109, 754109.1-754109.9. doi: 10.1155/2011/754109

Proteomics in molecular diagnosis: typing of amyloidosis

2009

Journal Article

Borderline High Serum Free Light Chain κ/λ Ratios Are Seen Not Only in Dialysis Patients but Also in Non–Dialysis-Dependent Renal Impairment and Inflammatory States

Marshall, George, Tate, Jill and Mollee, P. (2009). Borderline High Serum Free Light Chain κ/λ Ratios Are Seen Not Only in Dialysis Patients but Also in Non–Dialysis-Dependent Renal Impairment and Inflammatory States. American Journal of Clinical Pathology, 132 (2), 309-309. doi: 10.1309/AJCP8VOT5TVLAQBQ

Borderline High Serum Free Light Chain κ/λ Ratios Are Seen Not Only in Dialysis Patients but Also in Non–Dialysis-Dependent Renal Impairment and Inflammatory States

2009

Journal Article

Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies

Mollee, Peter (2009). Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies. Clinical Biochemist Reviews, 30 (3), 93-103.

Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies

2009

Journal Article

Monoclonal Gammopathies – Clinical and Laboratory Issues

Tate, Jill, Mollee, Peter and Johnson, R. (2009). Monoclonal Gammopathies – Clinical and Laboratory Issues. Clinical Biochemist Reviews, 30 (3), 89-91.

Monoclonal Gammopathies – Clinical and Laboratory Issues

2009

Journal Article

Quantitative serum free light chain assay: Analytical issues

Tate, Jill, Bazeley, Sheree, Sykes, Stephen and Mollee, Peter (2009). Quantitative serum free light chain assay: Analytical issues. Clinical Biochemist Reviews, 30 (3), 131-140.

Quantitative serum free light chain assay: Analytical issues

2009

Journal Article

Quantitative serum free light chain assay--analytical issues

Tate, Jill, Bazeley, Sheree, Sykes, Stephen and Mollee, Peter (2009). Quantitative serum free light chain assay--analytical issues. The Clinical biochemist. Reviews, 30 (3), 131-40. doi: 10.1186/1471-2369-9-11

Quantitative serum free light chain assay--analytical issues

2009

Journal Article

Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation

Hall, S. L., Tate, J., Gill, D. and Mollee, P. (2009). Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation. Clinical Biochemist Reviews, 30 (3), 113-118.

Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation

2008

Journal Article

A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation

Hourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008). A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. British Journal of Haematology, 141 (6), 904-907. doi: 10.1111/j.1365-2141.2008.07149.x

A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation

2008

Journal Article

Prolonged haematological toxicity from the hyper-CVAD regimen: Manifestations, frequency, and natural history in a cohort of 125 consecutive patients

Gill, Saar, Lane, Steven, Crawford, Julie, Cull, Gavin, Joske, David, Joske, David, Marlton, Paula, Mollee, Peter, Prince, Miles and Seymour, John (2008). Prolonged haematological toxicity from the hyper-CVAD regimen: Manifestations, frequency, and natural history in a cohort of 125 consecutive patients. Annals of Hematology, 87 (9), 727-734. doi: 10.1007/s00277-008-0488-6

Prolonged haematological toxicity from the hyper-CVAD regimen: Manifestations, frequency, and natural history in a cohort of 125 consecutive patients

2008

Journal Article

A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse

Lane, Steven, Saal, Russell, Mollee, Peter, Jones, Mark, Grigg, Andrew, Taylor, Kerry, Seymour, John, Kennedy, Glen, Williams, Bronwyn, Grimmett, Karen, Griffiths, Vanessa, Gill, Devinder, Hourigan, Matthew and Marlton, Paula (2008). A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse. Leukemia & Lymphoma, 49 (3), 517-523. doi: 10.1080/10428190701817266

A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse

2007

Journal Article

Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

Morris, K. L., Tate, J. R., Gill, D., Kennedy, G., Wellwood, J., Marlton, P., Bird, R., Mills, A. K. and Molle, P. (2007). Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Internal Medicine Journal, 37 (7), 456-463. doi: 10.1111/j.1445-5994.2007.01368.x

Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

2007

Journal Article

Palifermin-induced Acanthosis Nigricans

Lane, S. W., Manoharan, S. and Mollee, P. N. (2007). Palifermin-induced Acanthosis Nigricans. Internal Medicine Journal, 37 (6), 417-418. doi: 10.1111/j.1445-5994.2007.01340.x

Palifermin-induced Acanthosis Nigricans

2007

Journal Article

Analytical performance of serum free light-chains assay

Tate, Jillian R., Mollee, Peter, Dimeski, Goce, Carter, Andrew C. and Gill, Devinder (2007). Analytical performance of serum free light-chains assay. Clinica Chimica Acta, 380 (1-2), 250-251. doi: 10.1016/j.cca.2007.02.004

Analytical performance of serum free light-chains assay